首页 正文

Cost-effectiveness of degarelix versus LHRH agonists in prostate cancer: a systematic review

{{output}}
Objective: The escalating incidence of prostate cancer poses a significant global public health challenge. Optimal utilization of resources is crucial for the effective deployment of funds among the diverse and emerging treatment... ...